Author： Lam Sum Wang Shan Gottesman Malcolm
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.8, 2008-08, pp. : 1111-1117
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Interferon-β1b in the treatment of multiple sclerosis
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. :
Access to resources
Recommend
Interferon-β-1b: A Review of its Use in Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. :
Interferon-β-1b of benefit in early multiple sclerosis
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
Interferon-β-1b: In Newly Emerging Multiple Sclerosis
By McKeage Kate
CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. :
Interferon-β-1b: Exacerbation of multiple sclerosis: case report
Reactions Weekly, Vol. 1, Iss. 1403, 2012-01 ,pp. :